Important Information
This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:
Note: Ultima Markets is currently developing a dedicated website for UK clients and expects to onboard UK clients under FCA regulations in 2026.
If you would like to proceed and visit this website, you acknowledge and confirm the following:
Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.
By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.
I confirm my intention to proceed and enter this websiteLockheed Martin (NYSE: LMT) is trading at around $473.00 USD per share. 52-week range: $410.11 – $618.95
Lockheed Martin Corp is a U.S. aerospace and defense company that develops fighter jets, missiles, space systems, and security technologies for government and commercial clients. It designs and manufactures advanced technologies including fighter jets (like the F-35), missile defense systems, space exploration vehicles, helicopters, and cybersecurity solutions. The company operates through four main business segments: Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space. Its primary customer is the U.S. government, though it also serves international allies and commercial partners.
Lockheed Martin’s stock dropped in 2025 mainly because of disappointing earnings, cost overruns in its flagship programs, and investor caution around defense budgets. The most recent decline came after the company reported weak Q2 results in July 2025.
Key Reasons Why Lockheed Martin Stock Dropped
Earnings Misses and Heavy Charges
F-35 Program Cost Overruns
Flat Revenue Growth
Defense Budget Uncertainty
Market Rotation and Macro Pressure
Analysts are divided on Lockheed Martin’s outlook. According to recent consensus data, the average 12-month price target sits around $480–$495, with a low estimate near $398–$432 and a high estimate between $565 and $600 . This means most forecasts cluster in the mid-$470s to low-$500s, suggesting modest upside from current levels. The bullish case depends on execution in programs like the F-35 and stability in U.S. defense budgets, while the bearish view highlights cost overruns and political risk.
Short-Term Forecast (2025–2026)
Long-Term Forecast (2026–2030)
Lockheed Martin is often viewed as a stable, dividend-paying stock with strong exposure to long-term defense spending. The company generates most of its revenue from U.S. government contracts, giving it reliable cash flows, and it has raised its dividend for more than 20 consecutive years. Analysts’ consensus rating is generally “Moderate Buy,” with average 12-month price targets around $480–$495.
Strengths
Risks
The decline in 2025 was driven by Q2 earnings weakness, $1.6 billion in program losses, negative free cash flow, and rising F-35 costs, alongside uncertainty over U.S. defense budgets. While Lockheed Martin remains a cornerstone defense contractor with a long contract backlog and steady dividends, near-term volatility is likely as the company works through execution challenges.
At Ultima Markets, we help traders navigate these market shifts by offering access to global equities, indices, and defense sector opportunities through our multi-asset trading platform. Whether you’re tracking Lockheed Martin, the broader aerospace industry, or looking for diversified trading strategies, Ultima Markets provides the tools, education, and insights you need to trade with confidence.
Disclaimer: This content is provided for informational purposes only and does not constitute, and should not be construed as, financial, investment, or other professional advice. No statement or opinion contained here in should be considered a recommendation by Ultima Markets or the author regarding any specific investment product, strategy, or transaction. Readers are advised not to rely solely on this material when making investment decisions and should seek independent advice where appropriate.